TD Cowen Reiterates Outperform Rating on CVS Health (CVS); Add on 'Trough Valuation'
Tweet Send to a Friend
TD Cowen analyst Charles Rhyee reiterated an Outperform rating and $111.00 price target on CVS Health (NYSE: CVS) saying the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
